Table 3.
Signal detection of clinical symptoms reported for adverse events associated with a neuraminidase inhibitor, oseltamivir.
| Clinical symptoms | Event (n) | PRR (kai2) | ROR (95% CI) | IC |
|---|---|---|---|---|
| Vomiting | 379 | 3.25 (15.51) | 3.30 (1.76, 6.21) | 0.08 |
| Hallucination | 209 | 4.48 (10.73) | 4.52 (1.68, 12.19) | 0.09 |
| Headache | 145 | 4.14 (7.06) | 4.17 (1.33, 13.10) | 0.09 |
| Insomnia | 128 | 3.66 (5.70) | 3.68 (1.17, 11.57) | 0.09 |
| Fatigue | 114 | 9.77 (7.85) | 9.83 (1.37, 70.45) | 0.11 |
| Dizziness | 112 | 9.59 (7.68) | 9.66 (1.35, 69.22) | 0.11 |
PRR, proportional reporting ratio; ROR, reporting odds ratios; CI, the confidence interval.